Future Market Insights.png
RFID in Pharmaceuticals Market to Reach USD 16,149 Million by 2034, Growing at a CAGR of 11.2% | Future Market Insights, Inc.
September 06, 2024 06:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 06, 2024 (GLOBE NEWSWIRE) -- RFID in the pharmaceuticals market is projected to grow significantly over the next decade, driven by increasing demands for tracking and monitoring...
7 Hills Logo.png
7 Hills Pharma Safely Doses First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors
September 03, 2024 14:02 ET | 7 Hills Pharma
7 Hills safely doses first cancer patient with alintegimod, a novel selective integrin activator designed to improve the efficacy of checkpoint blockade.
Global Electronic Article Surveillance (EAS) Antennas Market
Electronic Article Surveillance (EAS) Antennas Market Outlook, 2024-2030 - Rising Use in Supply Chain Management Spurs Demand, with Global Market Totalling $383 Million in Revenue by 2030
July 25, 2024 09:49 ET | Research and Markets
Dublin, July 25, 2024 (GLOBE NEWSWIRE) -- The "Electronic Article Surveillance (EAS) Antennas - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
BES_Mark.jpg
CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 05, 2024 22:00 ET | Bragar Eagel & Squire
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Checkpoint Therapeutics,...
Schall Firm Logo 2.jpg
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
June 04, 2024 10:20 ET | Schall Law
The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
7HP935 combined with umbilical cord blood may represent a new and better option for patients in need of HSCT.
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the Clinic
June 03, 2024 12:57 ET | 7 Hills Pharma
Houston biotech awarded $4.7MM in homegrown Texas support for new technology to safely improve the treatment of advanced blood cancers and genetic diseases
BES_Mark.jpg
CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. and Encourages Investors to Contact the Firm
May 31, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
Global Inventory Management Software Market
Inventory Management Software Market Report 2024-2028 and 2033 - A Projected $3.31 Billion Opportunity with Microsoft, Oracle, VMWare, Intuit, and NCR Corporation Dominating
May 30, 2024 08:01 ET | Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Inventory Management Software Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global inventory management...
Schall Firm Logo 2.jpg
7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
May 28, 2024 10:40 ET | Schall Law
The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
Schall Firm Logo 2.jpg
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm
May 21, 2024 11:00 ET | Schall Law
The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losses to Contact the Firm